Regulus Therapeutics Inc (RGLS)
2.27
+0.01
(+0.44%)
USD |
NASDAQ |
May 31, 16:00
2.295
+0.02
(+1.10%)
After-Hours: 20:00
Regulus Therapeutics Market Cap: 148.61M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 148.61M |
| May 30, 2024 | 147.95M |
| May 29, 2024 | 139.44M |
| May 28, 2024 | 133.88M |
| May 24, 2024 | 132.24M |
| May 23, 2024 | 125.69M |
| May 22, 2024 | 125.69M |
| May 21, 2024 | 123.73M |
| May 20, 2024 | 131.59M |
| May 17, 2024 | 130.93M |
| May 16, 2024 | 130.93M |
| May 15, 2024 | 132.24M |
| May 14, 2024 | 136.17M |
| May 13, 2024 | 136.82M |
| May 10, 2024 | 144.68M |
| May 09, 2024 | 147.30M |
| May 08, 2024 | 148.61M |
| May 07, 2024 | 145.99M |
| May 06, 2024 | 159.08M |
| May 03, 2024 | 173.48M |
| May 02, 2024 | 176.10M |
| May 01, 2024 | 164.32M |
| April 30, 2024 | 150.57M |
| April 29, 2024 | 164.97M |
| April 26, 2024 | 158.43M |
| Date | Value |
|---|---|
| April 25, 2024 | 148.61M |
| April 24, 2024 | 145.33M |
| April 23, 2024 | 147.95M |
| April 22, 2024 | 144.02M |
| April 19, 2024 | 139.44M |
| April 18, 2024 | 145.33M |
| April 17, 2024 | 153.19M |
| April 16, 2024 | 167.59M |
| April 15, 2024 | 181.99M |
| April 12, 2024 | 183.30M |
| April 11, 2024 | 181.99M |
| April 10, 2024 | 171.52M |
| April 09, 2024 | 176.76M |
| April 08, 2024 | 174.79M |
| April 05, 2024 | 166.28M |
| April 04, 2024 | 164.97M |
| April 03, 2024 | 170.86M |
| April 02, 2024 | 178.07M |
| April 01, 2024 | 183.30M |
| March 28, 2024 | 188.54M |
| March 27, 2024 | 188.54M |
| March 26, 2024 | 186.25M |
| March 25, 2024 | 184.61M |
| March 22, 2024 | 175.77M |
| March 21, 2024 | 181.99M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.258M
Minimum
Mar 16 2020
188.54M
Maximum
Mar 27 2024
41.05M
Average
27.30M
Median
Oct 09 2023
Market Cap Benchmarks
| ACADIA Pharmaceuticals Inc | 2.492B |
| Cassava Sciences Inc | 1.058B |
| Vertex Pharmaceuticals Inc | 117.50B |
| Cormedix Inc | 289.64M |
| Oragenics Inc | 9.051M |
Market Cap Related Metrics
| Price to Book Value | 1.381 |
| Price | 2.27 |
| Earnings Yield | -63.88% |